Closed-Loop System in the Management of Diabetes: Past, Present, and Future

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Diabetes Technology & Therapeutics

• Publication date

  2014-07-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/dia.2014.0193PMID 25072271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Continuous glucose monitoring

  2023cited by this paper
• Continuous Glucose Monitoring in Type 1 Diabetes

  2016cited by this paper
• National Estimates of Insulin-related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations

  2014cited by this paper
• The PILGRIM Study: In Silico Modeling of a Predictive Low Glucose Management System and Feasibility in Youth with Type 1 Diabetes During Exercise

  2014cited by this paper
• Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial

  2014cited by this paper
• Type 1 diabetes.

  2014cited by this paper
• Feasibility of Closed-Loop Insulin Delivery in Type 2 Diabetes: A Randomized Controlled Study

  2014cited by this paper
• National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations.

  2014cited by this paper
• Hypoglycemia Begets Hypoglycemia: The Order Effect in the ASPIRE In-Clinic Study

  2014cited by this paper
• Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

  2014cited by this paper
• First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas

  2014cited by this paper
• Adding Heart Rate Signal to a Control-to-Range Artificial Pancreas System Improves the Protection Against Hypoglycemia During Exercise in Type 1 Diabetes

  2014cited by this paper
• Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose

  2014cited by this paper
• Continuous Glucose Monitoring in the Subcutaneous Tissue over a 14-Day Sensor Wear Period

  2013cited by this paper
• Threshold-based insulin-pump interruption for reduction of hypoglycemia.

  2013cited by this paper
• Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.

  2013influential reference
• Nocturnal glucose control with an artificial pancreas at a diabetes camp.

  2013cited by this paper
• The Future of Basal Insulin

  2013cited by this paper
• Continuous glucose monitors: current status and future developments

  2013cited by this paper
• Continuous glucose monitoring in type 1 diabetes

  2013cited by this paper
• Response to Comment on: Cryer. Severe Hypoglycemia Predicts Mortality in Diabetes. Diabetes Care 2012;35:1814–1816

  2013influential reference
• Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial

  2013cited by this paper
• Self-Monitoring of Blood Glucose—An Overview

  2013cited by this paper
• Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

  2013cited by this paper
• A review of artificial pancreas technologies with an emphasis on bi‐hormonal therapy

  2013cited by this paper
• Outpatient Safety Assessment of an In-Home Predictive Low-Glucose Suspend System with Type 1 Diabetes Subjects at Elevated Risk of Nocturnal Hypoglycemia

  2013cited by this paper
• Use of Non-Insulin Therapies for Type 1 Diabetes

  2013cited by this paper
• Continuous Glucose Monitoring Systems: A Review

  2013cited by this paper
• Possible Impacts of New Accuracy Standards of Self-Monitoring of Blood Glucose

  2013cited by this paper
• Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes

  2013cited by this paper
• Algorithms for a Closed-Loop Artificial Pancreas: The Case for Model Predictive Control

  2013cited by this paper
• The “Glucositter” overnight automated closed loop system for type 1 diabetes: A randomized crossover trial

  2013cited by this paper
• Clinical Evaluation of a Personalized Artificial Pancreas

  2013cited by this paper
• HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes

  2013cited by this paper
• Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines

  2013cited by this paper
• Severe Hypoglycemia Predicts Mortality in Diabetes

  2012cited by this paper
• U‐100, pH‐Neutral formulation of VIAject®: faster onset of action than insulin lispro in patients with type 1 diabetes

  2012cited by this paper
• Insulin Infusion Set: The Achilles Heel of Continuous Subcutaneous Insulin Infusion

  2012cited by this paper
• Emerging diabetes therapies and technologies.

  2012cited by this paper
• Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes

  2012cited by this paper
• Undeniable Need for Ultrafast-Acting Insulin: The Pediatric Perspective

  2012cited by this paper
• Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus

  2012cited by this paper
• Hypoglycemia, Diabetes, and Cardiovascular Disease

  2012cited by this paper
• Does the Fat-Protein Meal Increase Postprandial Glucose Level in Type 1 Diabetes Patients on Insulin Pump: The Conclusion of a Randomized Study

  2012cited by this paper
• Stable Liquid Glucagon Formulations for Rescue Treatment and Bi-Hormonal Closed-Loop Pancreas

  2012cited by this paper
• The T1D Exchange clinic registry.

  2012cited by this paper
• A Fluorescent Responsive Hybrid Nanogel for Closed-Loop Control of Glucose

  2012cited by this paper
• The Use of an Automated, Portable Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes

  2012cited by this paper
• Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE Study

  2012influential reference
• Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy

  2011influential reference
• Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia

  2011cited by this paper
• Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes

  2011cited by this paper
• Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data

  2011cited by this paper
• Glucose Sensor Membranes for Mitigating the Foreign Body Response

  2011cited by this paper
• Meta-Analysis of Overnight Closed-Loop Randomized Studies in Children and Adults with Type 1 Diabetes: The Cambridge Cohort

  2011cited by this paper
• Automated Overnight Closed-Loop Glucose Control in Young Children with Type 1 Diabetes

  2011cited by this paper
• Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies

  2011cited by this paper
• How Basal Insulin Analogs Have Changed Diabetes Care

  2011cited by this paper
• Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes

  2011cited by this paper
• Amperometric Glucose Sensors: Sources of Error and Potential Benefit of Redundancy

  2010cited by this paper
• Insulin Patch Pumps: Their Development and Future in Closed-Loop Systems

  2010cited by this paper
• Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes

  2010cited by this paper
• Factors Influencing the Effectiveness of Glucagon for Preventing Hypoglycemia

  2010cited by this paper
• Continuous subcutaneous insulin infusion--an historical perspective.

  2010cited by this paper
• The Use of Insulin Pumps in Youth with Type 1 Diabetes

  2010cited by this paper
• Insulin Pump Use in Adults with Type 1 Diabetes—Practical Issues

  2010cited by this paper
• Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.

  2010cited by this paper
• Review of the Mechanism of Action and Clinical Efficacy of Recombinant Human Hyaluronidase Coadministration with Current Prandial Insulin Formulations

  2010cited by this paper
• Suspended insulin infusion during overnight closed‐loop glucose control in children and adolescents with Type 1 diabetes

  2010cited by this paper
• Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

  2010cited by this paper
• Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension

  2010cited by this paper
• MD-Logic Artificial Pancreas System

  2010cited by this paper
• Technologies for Continuous Glucose Monitoring: Current Problems and Future Promises

  2010cited by this paper
• Time lag characterization of two continuous glucose monitoring systems.

  2010cited by this paper
• System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197

  2010cited by this paper
• Prolonged Nocturnal Hypoglycemia Is Common During 12 Months of Continuous Glucose Monitoring in Children and Adults With Type 1 Diabetes

  2010cited by this paper
• Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring

  2009cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• An improved PID switching control strategy for type 1 diabetes.

  2008cited by this paper
• Continuous glucose monitoring and intensive treatment of type 1 diabetes.

  2008cited by this paper
• An Improved PID Switching Control Strategy for Type 1 Diabetes

  2008cited by this paper
• Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas

  2008cited by this paper
• Is There a Place for Insulin Pump Therapy in Your Practice

  2007cited by this paper
• Design, synthesis and crystallization of a novel glucagon analog as a therapeutic agent.

  2007cited by this paper
• Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Dual Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine

  2007cited by this paper
• Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability

  2006cited by this paper
• Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes

  2006cited by this paper
• Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial

  2006cited by this paper
• A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas

  2005cited by this paper
• Cognitive functioning in children with early onset type 1 diabetes and severe hypoglycemia.

  2005cited by this paper
• Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes.

  2004cited by this paper
• Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

  2004cited by this paper
• Mishandling of the Therapeutic Peptide Glucagon Generates Cytotoxic Amyloidogenic Fibrils

  2004cited by this paper
• Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.

  2003cited by this paper
• Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections in Adolescents with Type I Diabetes Mellitus: A Randomized Open Crossover Trial

  2003cited by this paper
• Predictors of acute complications in children with type 1 diabetes.

  2002cited by this paper
• A model-based algorithm for blood glucose control in Type I diabetic patients

  1999cited by this paper
• Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.

  1999cited by this paper
• Comparison of Human Regular and Lispro Insulins After Interruption of Continuous Subcutaneous Insulin Infusion and in the Treatment of Acutely Decompensated IDDM

  1998cited by this paper
• Continuous Subcutaneous Insulin Infusion

  1998cited by this paper

• Fully-Automated Patient-Agnostic Diabetes Management with Deep Reinforcement Learning

  2024cites this paper
• An Ultrasound-activated Transdermal Patch for Closed-loop Diabetes Management System

  2024cites this paper
• Technological advancements in glucose monitoring and artificial pancreas systems for shaping diabetes care

  2024cites this paper
• Differential signaling effects of blood glucose on delay discounting in individuals with and without type 1 diabetes

  2024cites this paper
• MESA 3: PRESENTE Y FUTURO DE LAS TERAPIAS BIOLÓGICAS PARA EL TRATAMIENTO DE LA DIABETES MELLITUS TIPO 1

  2023cites this paper
• Model Predictive Control with Dynamic Positive Input Extension for Artificial Pancreas Applications

  2023cites this paper
• Recent advancements in noninvasive glucose monitoring and closed-loop management systems for diabetes.

  2022cites this paper
• What is holding back glucometer use? -A comparative study of rural and urban India.

  2022cites this paper
• Patient-specific deep offline artificial pancreas for blood glucose regulation in type 1 diabetes

  2022cites this paper
• A Light Activated Glucagon Trimer with Resistance to Fibrillation.

  2021cites this paper
• Recent Advances in Insulin Delivery Devices and Modes of Insulin Therapy

  2021cites this paper
• Control of Type 1 Diabetes Mellitus using Particle Swarm Optimization driven Receding Horizon Controller

  2021cites this paper
• Wearable patch delivery system for artificial pancreas health diagnostic-therapeutic application: A review.

  2021cites this paper
• 10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes

  2020cites this paper
• Low glucose suspend systems

  2020cites this paper
• Severe Hypoglycemia: Is It Still a Threat for Children and Adolescents With Type 1 Diabetes?

  2020cites this paper
• RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020

  2020cites this paper
• Model Based Control for Insulin Infusion System in Postoperative Diabetic Patients: A Novel Approach

  2020influential citation
• Standardized Hybrid Closed-Loop System Reporting

  2020cites this paper
• Design of dual hormone blood glucose therapy and comparison with single hormone using MPC algorithm.

  2020cites this paper
• Control of Complex Biological Systems Utilizing the Neural Network Predictor

  2019cites this paper
• An opportunity of using Robust Fixed Point Transformation-based controller design in case of Type 1 Diabetes Mellitus

  2019cites this paper
• Receding Horizon Control of Type 1 Diabetes Mellitus by Using Nonlinear Programming

  2018cites this paper
• Risk analysis for the design of a safe artificial pancreas control system

  2018cites this paper
• RECENT TRENDS IN THE MODELING AND CONTROL OF THE GLUCOSE-INSULIN SYSTEM

  2018cites this paper
• Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System

  2018cites this paper
• Conductive polylactic-acid filament for dose monitoring in syringe-less wearable infusion pump

  2018cites this paper
• Risk analysis for the design of a safe artificial pancreas control system

  2018cites this paper
• Severe hypoglycemia is associated with high risk for falls in adults with type 1 diabetes

  2018cites this paper
• The Future of Continuous Glucose Monitoring

  2017cites this paper
• Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar® in Type 1 Diabetes Management

  2017cites this paper
• Closed loop control of blood glucose level with neural network predictor for diabetic patients

  2017cites this paper
• Flash Glucose Monitoring: The Future Is Here

  2017cites this paper
• Robust nonlinear model predictive control of diabetes mellitus

  2017cites this paper
• Proportional Insulin Infusion in Closed-Loop Control of Blood Glucose

  2017cites this paper
• Neuroessentialism in Discussions About the Impact of Closed-Loop Technologies on Agency and Identity

  2017cites this paper
• A robust fixed point transformation-based approach for type 1 diabetes control

  2017cites this paper
• Relational Agency: Yes—But How Far? Vulnerability and the Moral Self

  2017cites this paper
• iDECIDE: An Evidence-based Decision Support System for Improving Postprandial Blood Glucose by Accounting for Patient’s Preferences

  2017cites this paper
• Linear parameter varying (LPV) based robust control of type-I diabetes driven for real patient data

  2017cites this paper
• Closed-Loop Controller Design Possibilities for Nonlinear Physiological Systems

  2017cites this paper
• Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas.

  2016influential citation
• Control of T1DM via tensor product-based framework

  2016cites this paper
• Long-term prediction for T1DM model during state-feedback control

  2016cites this paper
• Comparison of bioartificial and artificial pancreatic transplantation as promising therapies for Type I Diabetes Mellitus

  2016cites this paper
• Convex polytopic modeling of diabetes mellitus: A Tensor Product based approach

  2016cites this paper
• Insulin delivery methods: Past, present and future

  2016cites this paper
• An Overview of Insulin Pumps and Glucose Sensors for the Generalist

  2016cites this paper
• The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes

  2016cites this paper
• Successful Application of Closed‐Loop Artificial Pancreas Therapy After Islet Autotransplantation

  2016cites this paper
• The Pathobiology of Diabetes Mellitus

  2016cites this paper
• Pursuit of a perfect insulin

  2016cites this paper
• Investigation of the TP-based modeling possibility of a nonlinear ICU diabetes model

  2016cites this paper
• Research Update—Closed Loop/Artificial Pancreas

  2016cites this paper
• LPV-based quality interpretations on modeling and control of diabetes

  2016cites this paper
• Psychosocial Impact of the Bionic Pancreas During Summer Camp

  2016cites this paper
• Managing diabetes in the digital age

  2015cites this paper
• Best Practice & Research Clinical Endocrinology & Metabolism

  2015cites this paper
• Simulation & control in type 1 diabetes

  2015cites this paper
• The Future of the Artificial Pancreas

  2015cites this paper
• Physical Activity Capture Technology With Potential for Incorporation Into Closed-Loop Control for Type 1 Diabetes

  2015cites this paper
• Développement de fragments d’anticorps ciblant ZnT8 pour l’imagerie fonctionnelle des cellules bêta pancréatiques

  2015cites this paper
• Analysis of a novel time-delay diabetes model

  2015cites this paper
• In Vivo Performance and Biocompatibility of a Subcutaneous Implant for Real-Time Glucose-Responsive Insulin Delivery

  2015cites this paper
• Hypo- and Hyperglycemic Alarms

  2015cites this paper
• Closed loop insulin delivery in diabetes.

  2015cites this paper
• Glucagon – the new ‘insulin’ in the pathophysiology of diabetes

  2015cites this paper
• Youth and Parent Measures of Self-Efficacy for Continuous Glucose Monitoring: Survey Psychometric Properties

  2015cites this paper
• Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

  2015cites this paper
• Examination of a novel double diabetes model

  2015cites this paper
• Fasting in Ramadan with an insulin pump.

  2015cites this paper
• Psychological Aspects Related to Diabetes Mellitus

  2015cites this paper
• Adaptive control solution for T1DM control

  2015cites this paper
• Glucose-responsive Implantable Polymeric Microdevices for “Smart” Insulin Therapy of Diabetes

  2014cites this paper
• Use of Non-Insulin Therapies for Type 1 Diabetes

  2013cites this paper